Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
PMM2,Phosphomannomutase 2,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",23241,79,1.20 [0.85-1.69],0.3080444452785321
PMM2,Phosphomannomutase 2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23728,126,1.02 [0.77-1.36],0.8703342161085106
PMM2,Phosphomannomutase 2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",23519,867,1.11 [0.99-1.23],0.0632818576959811
PMM2,Phosphomannomutase 2,Chapter I Certain infectious and parasitic diseases,Candidiasis,23745,261,1.06 [0.88-1.29],0.532666557137754
PMM2,Phosphomannomutase 2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,23070,2337,1.07 [1.00-1.14],0.0474508836261988
PMM2,Phosphomannomutase 2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),23292,1765,1.06 [0.99-1.14],0.1161685595742198
PMM2,Phosphomannomutase 2,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,23574,844,1.08 [0.97-1.21],0.1447803813617963
PMM2,Phosphomannomutase 2,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,23682,37,0.84 [0.49-1.42],0.5082616014354854
PMM2,Phosphomannomutase 2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,22662,538,1.15 [1.00-1.31],0.0427164285444878
PMM2,Phosphomannomutase 2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,21906,516,1.20 [1.05-1.38],0.0074080983510797
PMM2,Phosphomannomutase 2,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,22122,148,1.19 [0.93-1.54],0.1735857069297563
PMM2,Phosphomannomutase 2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,17617,1023,1.12 [1.02-1.24],0.0240109227886288
PMM2,Phosphomannomutase 2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,21925,249,1.25 [1.03-1.51],0.0252038001603721
PMM2,Phosphomannomutase 2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,23718,988,1.08 [0.98-1.19],0.1375990780774727
PMM2,Phosphomannomutase 2,Chapter I Certain infectious and parasitic diseases,Mycoses,23801,317,1.07 [0.90-1.28],0.4267298634375767
PMM2,Phosphomannomutase 2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,23180,528,1.19 [1.04-1.36],0.0116739082540384
PMM2,Phosphomannomutase 2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23751,589,1.16 [1.02-1.31],0.0244133061830576
PMM2,Phosphomannomutase 2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22858,128,1.00 [0.75-1.32],0.9869547395138594
PMM2,Phosphomannomutase 2,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,23842,28,1.69 [0.98-2.91],0.0599511495374529
PMM2,Phosphomannomutase 2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,23681,519,1.13 [0.99-1.30],0.0687699802716893
PMM2,Phosphomannomutase 2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23709,64,1.06 [0.72-1.57],0.7554081132975771
PMM2,Phosphomannomutase 2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23752,152,1.46 [1.15-1.86],0.00188841923292
PMM2,Phosphomannomutase 2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23738,138,1.44 [1.12-1.86],0.0042439181484425
PMM2,Phosphomannomutase 2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,22946,294,1.09 [0.91-1.31],0.3589439012639948
PMM2,Phosphomannomutase 2,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,22858,206,1.00 [0.80-1.25],0.9893392169041888
PMM2,Phosphomannomutase 2,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,22797,67,1.24 [0.85-1.81],0.2589643194455644
PMM2,Phosphomannomutase 2,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,23816,43,1.18 [0.73-1.89],0.5047780929639137
PMM2,Phosphomannomutase 2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23787,112,0.88 [0.65-1.19],0.4035034259166111
PMM2,Phosphomannomutase 2,Chapter I Certain infectious and parasitic diseases,Viral warts,23712,37,0.64 [0.37-1.10],0.1074788713777794
PMM2,Phosphomannomutase 2,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],23718,43,1.06 [0.66-1.71],0.8126020100432252
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,Benign lipomatous neoplasm,23585,271,1.14 [0.95-1.38],0.1691130867363089
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23765,62,1.38 [0.94-2.01],0.1007102430353532
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23740,66,1.08 [0.74-1.59],0.6799905059568168
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,10630,36,1.29 [0.76-2.17],0.3413800744432909
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",23663,997,0.99 [0.89-1.09],0.7711850563885769
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,Benign neoplasm of meninges,23831,44,1.17 [0.74-1.86],0.509844233040625
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23811,46,0.78 [0.48-1.26],0.3079959310352771
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,23822,79,1.17 [0.82-1.65],0.3843955328665818
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,Benign neoplasm of ovary,13155,83,1.10 [0.78-1.54],0.5852855389215761
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,Benign neoplasm: Ascending colon,23834,234,1.04 [0.84-1.27],0.7372655841952805
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,Benign neoplasm: Caecum,23830,181,1.07 [0.85-1.35],0.5718419500430609
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23775,45,1.16 [0.73-1.84],0.534901535765899
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,Benign neoplasm: Descending colon,23838,154,0.94 [0.73-1.22],0.6629151121545864
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,Benign neoplasm: Rectum,23804,242,0.91 [0.74-1.12],0.3789580967017062
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23772,465,1.04 [0.90-1.20],0.5922908965093078
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,Benign neoplasm: Transverse colon,23834,259,1.03 [0.85-1.25],0.76426191121389
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,Carcinoma in situ of breast,11293,74,0.63 [0.43-0.93],0.0199807346573426
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",11332,84,0.85 [0.59-1.21],0.3567456802289593
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",20582,31,0.92 [0.52-1.65],0.7866349139297351
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",20584,33,1.13 [0.65-1.95],0.6638571992573825
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23803,93,1.11 [0.80-1.53],0.5221682623247771
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,"Haemangioma, any site",23803,91,1.07 [0.77-1.49],0.6683832844315581
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,Leiomyoma of uterus,12603,340,0.90 [0.75-1.07],0.2144392678260832
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,Lung cancer and mesothelioma,17659,147,1.07 [0.81-1.40],0.6403098066505568
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,Lymphoid leukaemia,20577,26,0.98 [0.52-1.85],0.9514710601869594
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",20678,127,1.12 [0.85-1.48],0.4111371906320505
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",20626,75,1.39 [0.98-1.97],0.0667585155051292
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",11378,66,0.77 [0.51-1.15],0.1974570153210446
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",20596,45,0.91 [0.56-1.48],0.7057530241867893
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",20601,50,0.98 [0.62-1.54],0.9326390966901394
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",20614,63,1.23 [0.84-1.82],0.2878359662417159
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",11359,47,1.56 [1.02-2.38],0.0397079291182357
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",20600,49,1.29 [0.83-2.00],0.2600698757459995
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",9580,341,1.07 [0.90-1.27],0.4382240053243129
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",20635,84,1.18 [0.84-1.66],0.3350413616109111
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",20597,46,1.26 [0.80-1.99],0.3140923965424535
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,20607,56,0.90 [0.58-1.39],0.6295097254127898
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,Melanocytic naevi,23642,190,1.08 [0.86-1.36],0.4998604552048311
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,Melanocytic naevi of trunk,23803,87,0.96 [0.68-1.35],0.8219111838373054
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,Melanoma in situ,20559,37,1.18 [0.71-1.97],0.5230852859501258
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",20604,53,1.18 [0.77-1.81],0.4539169369398885
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",20651,100,1.24 [0.91-1.69],0.1670250434778381
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",20649,98,1.10 [0.79-1.52],0.5859114217602992
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",20607,56,1.33 [0.88-1.99],0.1710548035361756
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,Other benign neoplasms of skin,23685,128,1.23 [0.94-1.61],0.1351884504144667
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",21101,550,0.97 [0.85-1.11],0.6862580190856507
PMM2,Phosphomannomutase 2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",21131,580,0.97 [0.85-1.11],0.6510141163408676
PMM2,Phosphomannomutase 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23596,255,1.01 [0.83-1.23],0.938974959721592
PMM2,Phosphomannomutase 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,22623,39,1.00 [0.60-1.67],0.993362148198743
PMM2,Phosphomannomutase 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,23407,66,1.50 [1.04-2.15],0.0299627341778626
PMM2,Phosphomannomutase 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,23145,1905,1.11 [1.04-1.20],0.0027837453169936
PMM2,Phosphomannomutase 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,22853,19,0.97 [0.47-2.01],0.9295646660907588
PMM2,Phosphomannomutase 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,23540,28,2.27 [1.37-3.77],0.0015099736378207
PMM2,Phosphomannomutase 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,23458,874,1.16 [1.04-1.29],0.0054126349127162
PMM2,Phosphomannomutase 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,23458,874,1.16 [1.04-1.29],0.0054126349127162
PMM2,Phosphomannomutase 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,22632,48,1.18 [0.76-1.85],0.4627719076661324
PMM2,Phosphomannomutase 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,23604,770,1.16 [1.04-1.29],0.0093484157479132
PMM2,Phosphomannomutase 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,23600,88,1.00 [0.71-1.40],0.990323041988551
PMM2,Phosphomannomutase 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,23388,47,1.15 [0.74-1.80],0.5340992994869036
PMM2,Phosphomannomutase 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,23379,38,1.31 [0.80-2.13],0.2858344159605261
PMM2,Phosphomannomutase 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,23677,165,0.96 [0.74-1.22],0.7176611477255839
PMM2,Phosphomannomutase 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,23772,60,1.27 [0.86-1.87],0.2314359257030177
PMM2,Phosphomannomutase 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",23654,142,0.79 [0.60-1.04],0.0922596703981694
PMM2,Phosphomannomutase 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,22892,58,0.88 [0.58-1.34],0.5531072420529216
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,20448,176,1.04 [0.82-1.32],0.7418236928326225
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,22166,104,1.12 [0.82-1.52],0.4829801711604198
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,22184,122,1.21 [0.91-1.60],0.1921072662327685
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,20303,31,1.73 [1.03-2.90],0.0400782454368087
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,22126,64,0.79 [0.53-1.19],0.2650332074401005
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,21820,126,0.99 [0.75-1.31],0.9474171573641031
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",23714,139,1.05 [0.81-1.38],0.6978238814441622
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,23620,45,1.01 [0.63-1.63],0.9584327008943356
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,23607,32,1.46 [0.86-2.47],0.1619099728685696
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,23488,1426,1.05 [0.97-1.14],0.2219696045566597
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,21349,1386,1.05 [0.96-1.14],0.2998769381348841
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",20311,39,0.79 [0.47-1.32],0.3642479511931775
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",22422,50,0.86 [0.55-1.36],0.5296163907912623
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,20432,160,1.32 [1.04-1.69],0.0229316553152834
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,20325,53,1.36 [0.90-2.06],0.1447586062435697
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,22349,2077,1.14 [1.07-1.22],0.0001295737553615
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,20378,106,0.99 [0.73-1.35],0.938476035528472
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,20609,337,1.25 [1.05-1.47],0.0098772132999796
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23760,226,1.18 [0.96-1.45],0.1138029676902038
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,23626,92,1.40 [1.03-1.92],0.0327707962758107
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,20362,90,1.36 [0.99-1.87],0.0556723380328915
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",20306,34,1.42 [0.84-2.38],0.1908578815965489
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,23472,1100,1.14 [1.04-1.25],0.0049081419052689
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,20381,109,0.99 [0.73-1.35],0.9714388749772536
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,20400,128,0.93 [0.70-1.23],0.6087350292267644
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",20614,342,1.03 [0.87-1.22],0.7465336053080125
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,20328,56,1.35 [0.90-2.03],0.142395792415614
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,23620,86,1.32 [0.95-1.83],0.0958811568298428
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,20532,260,1.11 [0.91-1.35],0.2895758738898931
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,20540,268,1.13 [0.93-1.36],0.2214525157988051
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,21742,48,0.94 [0.59-1.50],0.8041947659970661
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,23238,2966,1.14 [1.08-1.21],6.97843263587652e-06
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,22395,23,0.87 [0.44-1.71],0.6839045045928451
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,22424,52,1.10 [0.72-1.70],0.6551024668461337
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,23686,1674,0.98 [0.91-1.06],0.6946740343154778
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",23688,1670,0.98 [0.91-1.06],0.6868753746503777
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,22403,31,1.79 [1.08-2.97],0.0234189820066986
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,23562,1068,1.09 [0.99-1.19],0.0898305351798454
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",21046,774,1.13 [1.01-1.26],0.0395695615456176
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,23836,105,0.87 [0.63-1.19],0.374623048425392
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,23606,31,1.16 [0.67-2.03],0.5965646396024502
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,22571,77,0.91 [0.63-1.31],0.621369383151937
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,22593,99,1.26 [0.93-1.71],0.1407045903715191
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",20381,109,1.53 [1.15-2.04],0.0033492932348135
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,22283,105,1.22 [0.91-1.65],0.1877572061805653
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1485,57,0.85 [0.55-1.31],0.4541663031968994
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1581,166,1.01 [0.79-1.30],0.91948328991658
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,22213,35,1.13 [0.70-1.82],0.6123281901365539
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1457,29,0.92 [0.51-1.68],0.7943431358753977
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,23488,1310,1.13 [1.03-1.23],0.0058933061993659
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,23634,59,0.82 [0.54-1.26],0.365941279809805
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,21939,245,1.09 [0.90-1.33],0.386547047507084
PMM2,Phosphomannomutase 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,20618,346,1.22 [1.03-1.44],0.0207723349135373
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23760,147,1.01 [0.78-1.31],0.9275842677940996
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),23191,49,0.95 [0.60-1.51],0.8317469072884235
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Angina pectoris,22748,691,1.02 [0.90-1.15],0.7660992207248865
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Aortic aneurysm,23235,93,1.22 [0.89-1.68],0.2255134280900224
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,23169,27,2.33 [1.38-3.92],0.0014780421727421
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",23236,94,1.19 [0.87-1.64],0.2813554975787025
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,16926,787,1.01 [0.90-1.12],0.926171187519746
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,AV-block,21700,158,0.89 [0.69-1.16],0.3955527480267986
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23812,225,0.80 [0.64-1.00],0.0452554983224273
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Cardiac arrest,16231,92,1.13 [0.82-1.55],0.4628599543961159
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,21656,114,0.87 [0.64-1.18],0.3657299879222536
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",21614,72,0.88 [0.60-1.29],0.5122267167703302
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,23844,15,0.42 [0.18-1.02],0.0551306440839958
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Conduction disorders,22006,464,1.00 [0.87-1.16],0.9739166656646572
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,23215,1166,1.12 [1.02-1.23],0.0138737408748226
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,22143,5225,1.07 [1.03-1.12],0.0013127534121391
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,22836,154,1.06 [0.82-1.36],0.6635298275325112
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Endocarditis,21582,40,0.56 [0.32-0.95],0.0314379353280606
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",23735,442,1.14 [0.98-1.32],0.0824361908231338
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Hypertension,22635,4257,1.08 [1.03-1.14],0.0010883927074003
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",22643,4265,1.08 [1.03-1.14],0.0011101004960683
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,"Hypertension, portal",23692,48,0.82 [0.52-1.31],0.4127657598960494
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",18457,79,1.02 [0.71-1.45],0.9216786667269306
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,18417,39,0.67 [0.39-1.14],0.1390983667365203
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Hypotension,23757,591,0.99 [0.87-1.13],0.9201456457895434
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,23384,57,0.89 [0.58-1.36],0.5822203141106392
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",23352,1295,1.08 [0.99-1.18],0.0655938710273129
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",23649,270,1.10 [0.91-1.33],0.3267869822412297
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Left bundle-branch block,21724,182,1.19 [0.95-1.50],0.1277406355112687
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,23623,523,1.07 [0.93-1.23],0.3337002740022634
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",22482,425,1.09 [0.94-1.27],0.2631672151175535
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23793,105,0.74 [0.54-1.02],0.0676885160216499
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",23829,182,1.17 [0.93-1.47],0.1798308215146213
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Oesophageal varices,22713,31,0.74 [0.41-1.32],0.308949318667812
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Other aneurysm,23181,39,0.70 [0.41-1.19],0.1897789213198331
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Other arrhythmias,21764,222,1.08 [0.87-1.33],0.4839527568643832
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,23201,59,1.72 [1.18-2.50],0.0051513102752197
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,23270,128,1.11 [0.84-1.46],0.4736143187189164
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,21653,111,0.91 [0.67-1.24],0.5659896539113264
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Other disorders of veins,22743,61,0.97 [0.64-1.45],0.8668194999278978
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,22727,45,0.90 [0.56-1.45],0.6718717669550669
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,23162,34,0.94 [0.54-1.64],0.8358269298087727
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,22760,78,0.75 [0.52-1.08],0.1196649374802449
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,22054,512,1.02 [0.89-1.17],0.808287042338725
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,23206,40,0.68 [0.41-1.15],0.1509077712954692
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,23444,302,1.14 [0.96-1.37],0.1374759526681007
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,23454,137,1.13 [0.86-1.47],0.3823668742562838
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",23333,205,1.07 [0.86-1.34],0.5203613685579922
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,16345,206,0.95 [0.76-1.19],0.6517204197703181
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,23302,181,1.10 [0.87-1.38],0.4366980451734682
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22897,215,1.14 [0.92-1.40],0.2401185023651508
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,23603,286,1.09 [0.90-1.31],0.3729501583599116
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23806,282,1.03 [0.85-1.24],0.7685583099096114
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Right bundle-branch block,21687,145,0.89 [0.68-1.16],0.3768808954349971
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,23451,134,1.16 [0.89-1.51],0.2864123540853724
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,23225,97,1.10 [0.80-1.52],0.5441690102852056
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",23643,316,1.05 [0.88-1.25],0.5977508434633911
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",23621,348,1.02 [0.86-1.21],0.8258341713447304
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,23365,50,0.98 [0.62-1.54],0.9288698700393148
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,23190,49,0.94 [0.60-1.49],0.8039434625398987
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,23494,115,1.19 [0.89-1.58],0.2427635713836206
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,23257,157,1.09 [0.85-1.40],0.4837499964646187
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Varicose veins,22951,269,0.86 [0.71-1.05],0.1343213566290931
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,23152,45,0.85 [0.52-1.37],0.5005645808459889
PMM2,Phosphomannomutase 2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,23686,449,1.09 [0.94-1.27],0.2325152797424159
PMM2,Phosphomannomutase 2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23700,319,0.98 [0.82-1.17],0.8257976705488048
PMM2,Phosphomannomutase 2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",21232,1225,1.09 [1.00-1.20],0.0484582241272358
PMM2,Phosphomannomutase 2,Chapter V Mental and behavioural disorders,Any mental disorder,23183,3176,1.02 [0.97-1.08],0.419952212398634
PMM2,Phosphomannomutase 2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23646,371,0.96 [0.81-1.13],0.619271583228048
PMM2,Phosphomannomutase 2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",21464,1457,1.04 [0.96-1.13],0.3847837895508514
PMM2,Phosphomannomutase 2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",20084,77,1.04 [0.72-1.49],0.8474697027098721
PMM2,Phosphomannomutase 2,Chapter V Mental and behavioural disorders,Smoking dependency,23363,1328,1.02 [0.93-1.11],0.6797995723764427
PMM2,Phosphomannomutase 2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",21528,1521,1.02 [0.94-1.10],0.6516255921906373
PMM2,Phosphomannomutase 2,Chapter V Mental and behavioural disorders,Vascular dementia,23745,17,0.94 [0.44-2.02],0.8769229182622361
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Alzheimer disease,23843,63,0.99 [0.66-1.48],0.9589650193666802
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Bell's palsy,22397,68,0.86 [0.58-1.27],0.4568627732721636
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22748,419,0.97 [0.83-1.13],0.6891124250681324
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Cerebral cysts,23529,178,1.24 [0.99-1.56],0.0658386601914014
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23768,187,0.92 [0.73-1.17],0.4959812995728927
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,23714,22,1.49 [0.79-2.80],0.215183942050491
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,23833,49,1.25 [0.81-1.93],0.3206079545707728
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",23403,52,1.08 [0.70-1.67],0.7200532539837454
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Epilepsy,22493,222,1.09 [0.89-1.35],0.407231993388662
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,23418,1147,1.04 [0.95-1.14],0.3597613390716366
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,23816,167,1.06 [0.83-1.36],0.6178240894210373
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,23398,1424,0.97 [0.89-1.06],0.5076620412838186
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Generalized epilepsy,23518,44,1.38 [0.88-2.18],0.1595303787902005
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Hemiplegia,23717,136,1.00 [0.76-1.31],0.9966028200821802
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Hydrocephalus,23395,44,1.79 [1.16-2.75],0.0082965155561978
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,23822,59,1.31 [0.88-1.94],0.1822247126813532
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,22393,64,1.06 [0.71-1.56],0.7861841373442184
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,22399,70,1.11 [0.76-1.61],0.5876123282045238
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Memory loss,23713,65,1.00 [0.67-1.47],0.9825132560990976
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Migraine,22632,361,1.10 [0.93-1.29],0.2630489939926481
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23767,327,1.08 [0.91-1.29],0.3516820531680544
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Motor neuron disease,17327,91,1.31 [0.95-1.81],0.0975574916595162
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23658,130,0.85 [0.64-1.13],0.2628335711281107
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",23314,985,1.03 [0.93-1.14],0.5248697398170257
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Neurological diseases,22578,2631,1.04 [0.98-1.11],0.1998062403715318
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,23757,65,1.11 [0.75-1.64],0.5950102950984336
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",22664,335,1.08 [0.91-1.28],0.3866195851637978
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",23784,203,0.95 [0.76-1.19],0.6662155483028984
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,19877,276,1.02 [0.84-1.24],0.8214881588075551
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,23403,52,0.89 [0.57-1.39],0.6157914302668765
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Other disorders of nervous system,23453,102,1.13 [0.83-1.54],0.423018718446506
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,23720,71,0.81 [0.55-1.20],0.2937470380214836
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Other facial nerve disorders,22415,86,0.81 [0.57-1.15],0.2467497786026382
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Other headache syndromes,22327,56,1.23 [0.82-1.85],0.3167828930790852
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Other neurological diseases,23736,385,1.21 [1.04-1.42],0.0151019157117137
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Other sleep disorders,22774,503,0.98 [0.85-1.13],0.762926089451347
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Parkinson's disease,23830,75,1.01 [0.70-1.46],0.9607318440929888
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,23406,55,1.48 [1.00-2.20],0.0494219513773173
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Restless leg syndrome,23842,33,1.11 [0.65-1.90],0.700554606430656
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Sleep apnoea,23635,442,0.99 [0.86-1.15],0.9291492821478552
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Small fibre neuropathy,23613,32,1.16 [0.67-2.01],0.6035402593040115
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,23828,115,1.04 [0.78-1.40],0.7697991910621367
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,22356,27,0.97 [0.53-1.80],0.9295922666357586
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,23843,64,1.03 [0.69-1.53],0.8853986517988901
PMM2,Phosphomannomutase 2,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),23733,16,0.92 [0.42-2.03],0.8412178353034399
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,23418,34,0.94 [0.54-1.63],0.8296974296127131
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,23528,185,1.06 [0.84-1.34],0.623774411154403
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23772,168,1.00 [0.78-1.27],0.9687159587989814
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,23189,33,0.56 [0.31-1.01],0.0553327140465298
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,23222,66,1.14 [0.78-1.67],0.5121070950383974
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",23760,29,0.98 [0.54-1.76],0.9421608773442112
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,23677,58,1.09 [0.72-1.66],0.6679236216903457
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1460,32,1.01 [0.57-1.77],0.982400077267872
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,1725,68,0.83 [0.55-1.23],0.35009825826909
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,23459,75,1.05 [0.73-1.51],0.7908311731843375
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,23738,540,1.10 [0.96-1.25],0.1759364494609702
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23570,414,0.91 [0.78-1.07],0.25155570931423
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,23276,120,0.72 [0.53-0.97],0.0327424593320546
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23762,419,1.05 [0.90-1.23],0.4958246876693252
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,23835,50,0.81 [0.51-1.28],0.362182117030717
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,23696,353,1.02 [0.86-1.20],0.8599577939959955
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",23807,188,1.04 [0.83-1.32],0.7101121437817934
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,23789,116,0.90 [0.67-1.22],0.5028355798014217
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,23171,15,0.83 [0.35-1.93],0.658761239987957
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,23182,26,1.22 [0.66-2.24],0.5268960367617754
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,23186,30,0.57 [0.31-1.06],0.076286366370789
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23803,331,1.04 [0.88-1.24],0.6342177941669371
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,23552,80,0.83 [0.58-1.20],0.3180014672452382
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,23364,21,1.14 [0.58-2.24],0.7032811785541739
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,23679,60,1.16 [0.78-1.73],0.4698361690113336
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,23749,130,1.03 [0.78-1.36],0.819608538762564
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,23489,146,0.95 [0.73-1.24],0.6951475476933997
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,23739,66,0.94 [0.63-1.39],0.7482396101868808
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,23687,215,1.15 [0.93-1.43],0.1828194787400592
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,23482,98,1.18 [0.86-1.61],0.3030818055399537
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,23224,926,1.10 [0.99-1.22],0.0725541054569585
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,23727,108,1.14 [0.84-1.54],0.4014115708390124
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,23821,97,1.36 [1.00-1.85],0.0470281629289362
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,23384,228,0.95 [0.77-1.18],0.6451495956123257
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,23655,36,0.97 [0.57-1.66],0.9147664277335706
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,23819,34,0.81 [0.46-1.42],0.4581274444141446
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,23192,36,0.88 [0.51-1.51],0.6434055789565453
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,23256,100,1.00 [0.73-1.37],0.9983720374980578
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,23255,57,0.85 [0.55-1.30],0.4482437758625812
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,23391,48,1.19 [0.76-1.85],0.4473972791003584
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",23241,43,0.92 [0.56-1.49],0.7224160245981687
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,23518,46,1.07 [0.67-1.70],0.7850485394300879
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",23553,81,0.90 [0.63-1.29],0.5795167832498386
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,23231,75,1.07 [0.74-1.53],0.7274854845832188
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,23302,104,1.48 [1.10-1.98],0.00873305081116
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,23227,29,1.06 [0.59-1.90],0.8432349221179379
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,23018,720,1.07 [0.95-1.20],0.2846178002419119
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,23200,44,0.52 [0.31-0.86],0.0112501672786458
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23652,268,1.06 [0.88-1.28],0.5521185559246764
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,23415,31,0.84 [0.47-1.52],0.572039539595369
PMM2,Phosphomannomutase 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),23494,110,1.11 [0.83-1.49],0.4878050085689178
PMM2,Phosphomannomutase 2,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,23667,58,0.78 [0.51-1.20],0.258859799959889
PMM2,Phosphomannomutase 2,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,23803,78,0.78 [0.54-1.13],0.1896409923658337
PMM2,Phosphomannomutase 2,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,23734,122,0.76 [0.57-1.03],0.0735560080025422
PMM2,Phosphomannomutase 2,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,23658,49,0.97 [0.62-1.54],0.9089847385704942
PMM2,Phosphomannomutase 2,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,23660,51,1.32 [0.87-2.01],0.1976603428478801
PMM2,Phosphomannomutase 2,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,23761,460,1.01 [0.87-1.17],0.9275763392510256
PMM2,Phosphomannomutase 2,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,23590,289,1.08 [0.90-1.30],0.4310883252502063
PMM2,Phosphomannomutase 2,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,23384,83,1.03 [0.73-1.46],0.8605364013896255
PMM2,Phosphomannomutase 2,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,23367,66,0.90 [0.61-1.34],0.6018847317651
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,Acute pharyngitis,23588,69,0.79 [0.53-1.17],0.2420952571877004
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23729,210,0.89 [0.71-1.11],0.3021981906578552
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,23574,55,0.76 [0.49-1.18],0.2243890303592923
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,All influenza,22722,69,1.23 [0.85-1.78],0.2686872603081978
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),22721,68,1.28 [0.88-1.85],0.1969776040285419
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,Allergic asthma (mode),17629,117,1.02 [0.76-1.37],0.8693498647157237
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,Allergic rhinitis,23716,272,1.13 [0.94-1.37],0.1926311592188949
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",18910,1527,1.05 [0.97-1.14],0.248118200336533
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",19013,1501,1.06 [0.98-1.15],0.1331324088114896
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),23596,84,1.36 [0.98-1.89],0.0655334284789225
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",22703,50,1.49 [0.97-2.27],0.0660425462762846
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,Bronchiectasis,21201,155,1.22 [0.95-1.56],0.1196406358650148
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",21080,34,0.88 [0.51-1.53],0.6479936950236633
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,23077,2031,1.07 [1.00-1.14],0.0653436793279569
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",22559,58,1.30 [0.87-1.94],0.2026168921525635
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,Chronic sinusitis,22644,143,1.56 [1.22-2.00],0.0003861962532943
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",23752,615,1.15 [1.01-1.30],0.0302518673322478
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,Deviated nasal septum,22622,121,1.39 [1.05-1.82],0.0193204236868192
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,22158,3671,1.07 [1.02-1.13],0.0074279070011513
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22839,338,1.19 [1.01-1.41],0.0390774499241162
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,Early onset COPD,23577,440,1.17 [1.01-1.35],0.0390492774892982
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,Emphysema,21205,159,1.66 [1.32-2.09],1.5415225897862625e-05
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22728,100,1.11 [0.81-1.51],0.5138950191066076
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,23684,1031,1.14 [1.03-1.25],0.0102145145784661
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,Interstitial lung disease,22748,120,1.17 [0.88-1.55],0.2872083525852604
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,Later onset COPD,22583,175,1.14 [0.89-1.45],0.2893099653070147
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,23836,132,1.05 [0.80-1.38],0.7342343713285198
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,Nasal polyp,22603,102,1.25 [0.92-1.69],0.1507012373484248
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23650,548,1.14 [1.00-1.30],0.0565097019394032
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,Other diseases of pleura,23688,1083,1.14 [1.03-1.25],0.007541198802774
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,23276,775,1.22 [1.09-1.36],0.00050758181555
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,Other pleural conditions,22638,33,0.98 [0.57-1.71],0.9538962261871542
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23791,176,1.05 [0.83-1.33],0.6674077919220699
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23773,743,1.14 [1.02-1.28],0.0227964485348407
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,Pleural effusion,23122,517,1.16 [1.01-1.32],0.0382907438144006
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,Pleural plaque,22652,47,1.34 [0.87-2.09],0.187900527837291
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",23499,846,1.14 [1.03-1.27],0.0149265910538697
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,23819,115,1.09 [0.81-1.46],0.5701777903785203
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,Pneumothorax,22660,55,1.63 [1.10-2.42],0.0141868867102154
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,Pollen allergy,23812,232,1.10 [0.90-1.35],0.3517819959627328
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,Pulmonary oedema,23651,36,0.88 [0.52-1.50],0.6472055579676212
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,Respiratory insufficiency,17544,32,1.22 [0.70-2.13],0.4750526472002001
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,23630,528,1.12 [0.98-1.29],0.0906968229803786
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,22773,272,1.14 [0.94-1.38],0.1716193670833528
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,Viral pneumonia,22819,166,1.10 [0.87-1.40],0.4324373803077102
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",23613,143,1.04 [0.80-1.35],0.7847929992605003
PMM2,Phosphomannomutase 2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,13726,82,0.92 [0.65-1.32],0.6687220357449559
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,18233,56,0.93 [0.60-1.42],0.7236637075089761
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Acute appendicitis,23668,133,0.87 [0.66-1.15],0.3247186629611835
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Acute gastritis,19051,60,0.95 [0.63-1.44],0.8190220803775334
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Acute pancreatitis,22449,148,1.02 [0.78-1.32],0.904193148853532
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Acute peritonitis,23460,58,1.33 [0.90-1.99],0.1554473895222205
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Alcoholic liver disease,23169,73,1.07 [0.74-1.53],0.7225811081136149
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Barrett oesophagus,19298,307,1.01 [0.84-1.21],0.9138597134992564
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",22350,49,1.06 [0.68-1.66],0.7977177270704366
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",23491,49,1.06 [0.68-1.66],0.7944582192046961
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Cholecystitis,22457,156,1.04 [0.81-1.33],0.7789362302829685
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Cholelithiasis,23110,809,1.05 [0.95-1.18],0.3407690488762424
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Chronic gastritis,19206,215,1.06 [0.86-1.32],0.5848387364996195
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Chronic pancreatitis,22339,38,0.96 [0.57-1.61],0.8823676372846562
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",23716,72,0.70 [0.48-1.04],0.0763816007343892
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Coeliac disease,22599,97,1.47 [1.09-1.98],0.0123308675812178
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Collagenous colitis,22487,48,1.11 [0.71-1.74],0.6556184311861719
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23673,179,1.07 [0.85-1.35],0.5708922505710238
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Constipation,23658,1004,0.99 [0.90-1.10],0.8691754920038657
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Crohn disease,22518,79,1.29 [0.92-1.82],0.1433304187918619
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23540,53,1.53 [1.02-2.30],0.0391103899190942
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,22516,77,1.35 [0.96-1.90],0.087289322361812
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Dental caries,23123,227,1.16 [0.95-1.43],0.1423244642763298
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,22033,1550,1.06 [0.98-1.15],0.1628958002414954
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Diseases of appendix,23706,171,0.94 [0.73-1.20],0.5983455473809907
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Diseases of liver,23739,643,1.05 [0.93-1.19],0.4438411206549334
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",22320,3329,1.05 [0.99-1.10],0.1100294465570987
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23425,529,1.18 [1.03-1.34],0.0170087626860059
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23773,371,1.25 [1.07-1.46],0.0056256597001215
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,23009,113,1.35 [1.02-1.79],0.0373356265036323
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Diseases of salivary glands,22874,60,1.17 [0.78-1.74],0.4450289132206926
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,23599,1097,1.10 [1.00-1.21],0.0491635711834754
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Diseases of tongue,22879,107,1.03 [0.76-1.40],0.8386287017248928
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",23397,1096,1.06 [0.97-1.17],0.207843875015549
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,20293,2116,1.05 [0.98-1.12],0.1927274466349108
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Duodenal ulcer,19121,130,0.91 [0.68-1.21],0.5107898497928812
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23780,101,0.85 [0.61-1.17],0.3090622953348096
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23725,73,1.19 [0.83-1.70],0.3429136202302359
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,23186,90,0.85 [0.60-1.19],0.3349209367327723
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,18330,153,1.00 [0.77-1.29],0.9843354903185788
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Functional dyspepsia,19435,444,1.10 [0.95-1.28],0.2141657547232028
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Gastric ulcer,19240,249,0.87 [0.71-1.06],0.1706485210229087
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,20927,1936,1.09 [1.02-1.18],0.0132081728415938
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,19354,363,0.92 [0.78-1.09],0.3251373140777883
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,19410,6918,1.05 [1.01-1.09],0.0223575354031491
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,GI-bleeding,23376,874,1.02 [0.92-1.13],0.7223967555471171
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,22956,60,1.36 [0.92-2.00],0.1204108393580585
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,18958,1101,1.09 [0.99-1.20],0.0792550479551749
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",23142,46,1.14 [0.72-1.79],0.5831488563219016
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Hernia,22826,2343,1.04 [0.98-1.12],0.1899118127349459
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Impacted teeth,23734,68,1.29 [0.89-1.86],0.1748461990317595
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Impaction of intestines,18207,30,1.54 [0.90-2.65],0.1183078230722374
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Inguinal hernia,21074,591,1.05 [0.92-1.20],0.4862478524424801
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",20552,69,0.88 [0.59-1.32],0.5395893514643262
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,18240,63,0.99 [0.66-1.48],0.9499624003492428
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,22618,116,1.53 [1.16-2.01],0.00235235329304
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,18680,503,1.11 [0.97-1.28],0.138452559987611
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,23819,334,1.09 [0.92-1.30],0.295049539736718
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,23041,602,1.09 [0.96-1.24],0.1945526788169795
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,23199,760,1.15 [1.03-1.29],0.0156763751623568
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,19117,126,1.39 [1.06-1.82],0.016756310221247
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Oesophagitis,19415,424,1.12 [0.96-1.30],0.1490641014602503
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23806,116,1.13 [0.84-1.50],0.4177375990448081
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,20526,43,1.02 [0.63-1.65],0.9431299389258656
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,19309,1132,0.97 [0.88-1.07],0.5470237139899645
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,22469,168,1.12 [0.88-1.43],0.3372889750403337
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,22440,139,0.88 [0.67-1.16],0.3730508176007847
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Other diseases of intestine,19499,1322,1.01 [0.93-1.11],0.7633018659469821
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Other diseases of intestines,22407,4230,1.02 [0.97-1.07],0.515766849601276
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22881,167,1.11 [0.87-1.41],0.4171275373492292
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Other diseases of liver,23611,515,1.01 [0.88-1.16],0.891912524278934
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,19459,468,1.01 [0.87-1.17],0.9010650456887696
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Other diseases of pancreas,22371,70,1.30 [0.90-1.87],0.1642288827461226
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23728,326,1.25 [1.06-1.48],0.0085846721059781
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,19657,666,0.98 [0.87-1.11],0.8075278861417514
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,23389,887,1.02 [0.92-1.14],0.6746540535548424
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,23042,146,1.08 [0.83-1.40],0.5679215791723675
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,19223,1046,1.00 [0.91-1.11],0.9516273675611177
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),20513,1522,0.99 [0.91-1.08],0.8548003754630777
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,23167,71,0.77 [0.52-1.13],0.1834095573549512
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,23100,661,1.08 [0.96-1.22],0.1956448255391482
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",18380,203,1.33 [1.07-1.64],0.0099874002514458
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23711,86,1.03 [0.73-1.44],0.8643830304850779
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,18480,303,1.20 [1.00-1.43],0.0498835937047016
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22627,125,1.26 [0.96-1.66],0.0933372690033742
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Recurring oral aphthae,23834,55,1.16 [0.76-1.75],0.4949469647804013
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,22910,117,1.25 [0.95-1.66],0.1167327936943648
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Toxic colitis,22460,21,0.95 [0.47-1.91],0.8823714159732037
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,19156,165,1.08 [0.85-1.38],0.5330914079734514
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Ulcerative colitis,22568,129,1.50 [1.16-1.95],0.0021793645053398
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",22550,111,1.41 [1.06-1.87],0.0190120685441097
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Umbilical hernia,20717,234,0.89 [0.72-1.09],0.2597220537467014
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,18270,93,0.97 [0.70-1.35],0.8618150892710684
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Ventral hernia,20682,199,1.24 [1.00-1.55],0.0496810485891432
PMM2,Phosphomannomutase 2,Chapter XI Diseases of the digestive system,Volvulus,18235,58,1.21 [0.80-1.82],0.362951064902915
PMM2,Phosphomannomutase 2,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,23804,136,0.97 [0.73-1.27],0.8010107144869496
PMM2,Phosphomannomutase 2,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,23611,72,0.80 [0.54-1.17],0.2393989608164382
PMM2,Phosphomannomutase 2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,22559,131,1.04 [0.79-1.37],0.7664430818847227
PMM2,Phosphomannomutase 2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,23281,479,0.99 [0.85-1.14],0.8514537082744181
PMM2,Phosphomannomutase 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",22981,179,1.03 [0.81-1.30],0.8309780453513418
PMM2,Phosphomannomutase 2,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,22574,146,1.20 [0.93-1.55],0.1692194951565665
PMM2,Phosphomannomutase 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,23618,202,1.03 [0.83-1.29],0.7817553936441289
PMM2,Phosphomannomutase 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23757,341,1.03 [0.87-1.23],0.7003501108919963
PMM2,Phosphomannomutase 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,23452,36,1.62 [1.00-2.63],0.0479733081415487
PMM2,Phosphomannomutase 2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,22564,2216,1.03 [0.97-1.11],0.3266963951923374
PMM2,Phosphomannomutase 2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23440,369,0.96 [0.81-1.13],0.6304694036176115
PMM2,Phosphomannomutase 2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,23328,257,0.98 [0.80-1.19],0.8161277337088794
PMM2,Phosphomannomutase 2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23490,688,0.99 [0.88-1.12],0.862024019708899
PMM2,Phosphomannomutase 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",23831,40,1.53 [0.97-2.42],0.0702801933939268
PMM2,Phosphomannomutase 2,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,22482,54,0.97 [0.63-1.50],0.8957554712052267
PMM2,Phosphomannomutase 2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,23108,37,1.30 [0.79-2.12],0.3032375372272825
PMM2,Phosphomannomutase 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,23612,196,1.05 [0.84-1.31],0.6829713251331755
PMM2,Phosphomannomutase 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,22683,255,1.16 [0.96-1.41],0.1332644162002253
PMM2,Phosphomannomutase 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,22462,34,1.05 [0.61-1.81],0.8495321198214367
PMM2,Phosphomannomutase 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,23773,62,1.13 [0.76-1.68],0.5319093830843724
PMM2,Phosphomannomutase 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,22919,117,1.12 [0.84-1.50],0.428479004084223
PMM2,Phosphomannomutase 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23673,134,0.82 [0.62-1.09],0.1719820738969668
PMM2,Phosphomannomutase 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,23440,24,0.77 [0.40-1.51],0.4505078542904805
PMM2,Phosphomannomutase 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,22474,46,0.92 [0.57-1.49],0.7394358245408978
PMM2,Phosphomannomutase 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,23391,963,1.05 [0.95-1.16],0.3366616793699239
PMM2,Phosphomannomutase 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",22713,285,1.19 [0.99-1.43],0.0587912086314038
PMM2,Phosphomannomutase 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,22465,37,1.22 [0.73-2.02],0.449304441240426
PMM2,Phosphomannomutase 2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23772,233,0.89 [0.72-1.10],0.2858391085971602
PMM2,Phosphomannomutase 2,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,23471,55,0.76 [0.49-1.18],0.2220906977557751
PMM2,Phosphomannomutase 2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23730,191,0.80 [0.63-1.01],0.0605822027054721
PMM2,Phosphomannomutase 2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23817,149,0.96 [0.74-1.25],0.7805733680243987
PMM2,Phosphomannomutase 2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,22538,110,1.07 [0.79-1.44],0.6708077312857421
PMM2,Phosphomannomutase 2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,22596,168,1.10 [0.86-1.40],0.4592317434232916
PMM2,Phosphomannomutase 2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23812,144,0.96 [0.74-1.25],0.7675043220184818
PMM2,Phosphomannomutase 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",22542,114,0.98 [0.73-1.31],0.8826433491826997
PMM2,Phosphomannomutase 2,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,23815,104,1.11 [0.82-1.51],0.496119985481516
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,20890,117,1.16 [0.87-1.54],0.3048240132034205
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,22234,4024,1.00 [0.95-1.05],0.995876531444826
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,21075,2865,0.98 [0.92-1.04],0.4193172857891261
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,20858,85,0.95 [0.67-1.34],0.7526802504064838
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,21363,135,1.17 [0.89-1.52],0.2591972812837268
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,21370,142,1.07 [0.82-1.39],0.6182311691877018
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,23644,101,0.79 [0.57-1.09],0.149422034642241
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",21271,43,1.00 [0.61-1.63],0.994618488285786
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,18873,663,0.96 [0.85-1.08],0.496671254919977
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23789,114,0.92 [0.68-1.24],0.5824893430425166
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,21480,252,1.05 [0.86-1.29],0.6028246927405065
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,20819,5392,1.03 [0.99-1.08],0.1524661202586722
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,22635,92,1.04 [0.75-1.44],0.8233611121195739
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,20875,102,1.01 [0.74-1.39],0.9368929743411714
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,21310,537,1.01 [0.88-1.16],0.9013846214418784
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,23057,1829,1.06 [0.99-1.14],0.0985031299101305
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,20974,201,1.19 [0.96-1.48],0.1186920468883057
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,21033,260,1.25 [1.04-1.51],0.0190257975138374
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,20908,135,0.96 [0.73-1.26],0.7609149002136626
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,23378,34,0.87 [0.50-1.51],0.6228997132657095
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,19341,1131,0.94 [0.86-1.04],0.2131018324932729
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,18550,340,0.97 [0.82-1.16],0.7652640175608527
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23795,330,0.99 [0.83-1.17],0.8672536136528892
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,18277,67,1.21 [0.83-1.77],0.3229973039487669
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),18513,303,0.89 [0.74-1.07],0.2170409396356247
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,21061,288,1.07 [0.89-1.29],0.4530807142676755
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,18869,659,0.97 [0.85-1.09],0.5757826015132677
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,21253,25,0.55 [0.28-1.07],0.0798883169498933
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,21715,487,1.07 [0.93-1.23],0.3489618536899846
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,21477,249,1.02 [0.84-1.25],0.8426701676026331
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,18822,612,0.95 [0.84-1.08],0.463252175821392
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,20843,70,1.27 [0.88-1.83],0.1997500812084081
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",20826,53,0.94 [0.61-1.45],0.774108168307583
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,22593,50,1.12 [0.73-1.73],0.6100978090492473
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,23551,1008,1.03 [0.93-1.14],0.5599756834043619
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,23117,574,1.08 [0.95-1.23],0.2313669339109397
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23737,301,1.01 [0.84-1.21],0.9454547089587844
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,19764,1554,0.99 [0.92-1.08],0.8997536590661714
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,18273,63,0.73 [0.48-1.10],0.1279211173668229
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,20841,68,1.15 [0.79-1.67],0.4658394581822869
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,18235,25,1.06 [0.57-1.99],0.8444182875276776
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),18307,97,1.05 [0.76-1.44],0.762205657771996
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,22745,202,0.91 [0.73-1.14],0.4331238044822876
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,22754,211,1.08 [0.87-1.35],0.4662314030915241
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,23807,74,0.99 [0.69-1.43],0.9557769181474528
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",22590,1362,1.06 [0.97-1.15],0.1934362086378122
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,20880,107,0.76 [0.55-1.04],0.0888218626639217
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),18319,109,0.71 [0.52-0.97],0.0302839937094817
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,21783,555,0.99 [0.87-1.14],0.9265255436831116
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,19989,1779,1.01 [0.93-1.08],0.8811548765789077
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,23396,52,1.02 [0.66-1.58],0.9315544337024856
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,23819,69,0.94 [0.64-1.37],0.7336287309896175
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,20843,70,1.11 [0.77-1.62],0.5708705525625197
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",21737,964,1.09 [0.98-1.20],0.0960689101567511
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,20832,59,1.24 [0.83-1.85],0.297808926159445
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,19177,967,1.09 [0.99-1.20],0.0931978446108298
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,22635,92,1.03 [0.74-1.42],0.8743764330889385
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,20832,59,1.08 [0.72-1.63],0.7026054531584445
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,21331,103,1.22 [0.90-1.65],0.1955319214758297
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,21117,344,1.01 [0.85-1.20],0.8817559145655579
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,23534,190,1.13 [0.90-1.41],0.2962694933267696
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,21639,411,1.09 [0.93-1.27],0.2750476824525028
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23746,286,1.02 [0.85-1.23],0.8374352271984395
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,23827,33,1.03 [0.60-1.79],0.9083147153884148
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,20954,181,1.01 [0.80-1.28],0.9354363637689448
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,19108,532,1.06 [0.92-1.21],0.4402199672405091
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,21205,432,0.98 [0.84-1.14],0.7916367270543508
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],20922,149,1.21 [0.93-1.56],0.1529603196116964
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",18243,33,0.67 [0.38-1.19],0.17401680636577
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,19743,1533,1.07 [0.99-1.16],0.1056533491364271
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,18602,392,0.98 [0.83-1.15],0.7913436362408748
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,23421,77,1.26 [0.89-1.79],0.186819725636427
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",23776,43,1.07 [0.66-1.72],0.7813315013676081
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",22448,24,0.80 [0.41-1.54],0.4992886225082616
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,18281,71,0.91 [0.62-1.33],0.6271579193374532
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,21306,78,1.10 [0.77-1.57],0.5888182524729184
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,18514,304,1.01 [0.85-1.21],0.8854614823862033
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,21010,237,1.08 [0.88-1.32],0.472526112565916
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,21414,186,1.37 [1.10-1.71],0.0047198849791043
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,21321,93,1.08 [0.78-1.49],0.6478256256062183
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,20152,41,1.15 [0.71-1.86],0.5733810399406114
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",23830,36,1.10 [0.65-1.85],0.7178263725021317
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,21297,524,1.07 [0.93-1.23],0.3223584054632329
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],23422,78,0.90 [0.62-1.29],0.5558321047445929
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,22900,2127,1.07 [1.00-1.15],0.0398037616719525
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",20874,101,1.16 [0.85-1.58],0.3507195809674112
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,21544,316,1.02 [0.85-1.22],0.853680452775345
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,22613,167,1.25 [0.99-1.59],0.0591652933016047
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,21359,131,1.04 [0.79-1.37],0.7714821519389249
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,22165,937,1.00 [0.91-1.11],0.9365026161748696
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,21841,613,0.92 [0.81-1.05],0.2222598369315905
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],20812,39,1.05 [0.64-1.73],0.8432221077529821
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,23478,134,1.18 [0.91-1.54],0.2169462482601481
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,20907,134,1.08 [0.82-1.41],0.5943063960565382
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,20826,53,0.70 [0.45-1.11],0.1281411997098628
PMM2,Phosphomannomutase 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),18243,33,1.23 [0.72-2.10],0.4410452473641294
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,23392,726,1.17 [1.04-1.31],0.0089132932520522
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),9660,63,1.05 [0.71-1.55],0.8243956231241616
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,12877,70,0.83 [0.57-1.22],0.3551458822249734
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23581,268,1.00 [0.82-1.21],0.9758875035591016
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,23369,56,0.87 [0.56-1.33],0.5113509355191819
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,23216,550,1.06 [0.93-1.21],0.3897623018499289
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,23690,18,0.43 [0.19-0.96],0.0388409377552164
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,23698,157,1.01 [0.78-1.30],0.9373884811887088
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Cystitis,21891,135,0.84 [0.63-1.11],0.2161572242045994
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Dialysis,22707,41,1.07 [0.65-1.74],0.796417705048295
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,10304,982,1.03 [0.93-1.14],0.5142591248126562
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,12980,173,0.90 [0.71-1.15],0.4101563681663417
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Endometriosis,9712,115,1.08 [0.81-1.44],0.5986441980364251
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",9927,330,0.86 [0.72-1.03],0.0932841228626335
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,9973,376,1.06 [0.90-1.24],0.5041120784427895
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,20064,3663,1.06 [1.01-1.12],0.0260178754533578
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,23726,54,1.06 [0.69-1.62],0.7956245419398791
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Hydrocele,9394,72,1.18 [0.81-1.70],0.38832630078223
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,22592,191,1.10 [0.87-1.38],0.4260760514343459
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,9975,653,1.04 [0.92-1.18],0.5143905534575554
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,12864,206,1.02 [0.82-1.27],0.84152808717935
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),9413,91,1.01 [0.72-1.42],0.940638757610297
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Irregular menses,12874,106,0.63 [0.46-0.88],0.0056721827161738
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Menorrhagia,9856,259,1.09 [0.90-1.33],0.3664329016126365
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,21813,57,0.92 [0.60-1.40],0.6833512304438051
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,10806,1209,1.04 [0.95-1.14],0.3401486765436947
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,9369,47,0.87 [0.54-1.40],0.569709518060746
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,9680,83,1.73 [1.26-2.36],0.0006006425186782
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",23834,35,1.31 [0.78-2.17],0.3055643590087672
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",23838,39,0.86 [0.51-1.44],0.5734323800884815
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,23082,1326,1.09 [1.00-1.19],0.0386781502706227
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,22176,420,1.05 [0.90-1.22],0.5474487826789589
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,12860,53,0.91 [0.59-1.41],0.6849085804660131
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23800,259,1.10 [0.90-1.33],0.3575497536368642
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,9458,136,0.94 [0.71-1.24],0.6700651536717367
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,9427,105,0.91 [0.67-1.25],0.579271539340557
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,9387,65,1.08 [0.73-1.60],0.6831441146828259
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,23812,49,1.55 [1.02-2.36],0.0383376569655813
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,22727,971,1.14 [1.03-1.26],0.0088612753603775
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,12763,105,1.27 [0.95-1.70],0.1132157320464597
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,9668,71,1.12 [0.77-1.62],0.547294565729332
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",9795,198,1.02 [0.82-1.28],0.8496726703919508
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,9648,51,1.26 [0.82-1.94],0.2898043032908861
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,9686,89,1.17 [0.84-1.62],0.346261327194068
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,22622,221,1.11 [0.90-1.37],0.3169251349828909
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,23629,88,1.01 [0.72-1.41],0.973017234119706
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,9752,155,1.13 [0.88-1.45],0.3466750387892257
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,9666,69,1.32 [0.92-1.90],0.1277902224014804
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,9953,356,1.03 [0.87-1.22],0.7219837483934557
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,9652,55,1.32 [0.88-1.98],0.1800024938635461
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,9915,318,1.02 [0.85-1.22],0.8283687876905025
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,23714,42,1.46 [0.92-2.32],0.1072418281255318
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",9418,96,1.02 [0.74-1.41],0.8810848669071032
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,23687,1286,1.10 [1.01-1.20],0.0255391341681665
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",22521,120,1.11 [0.83-1.47],0.4892741988399293
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,22720,54,0.87 [0.56-1.35],0.5308332197541741
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,23374,61,1.52 [1.05-2.22],0.028001753497303
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,21905,149,1.19 [0.92-1.53],0.1827416684977724
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,23639,326,1.00 [0.84-1.19],0.985499376099046
PMM2,Phosphomannomutase 2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,9681,84,1.22 [0.87-1.70],0.2470034938525681
